International Clinical Trial: Establishment of a new method for blood concentration of camrelizumaband association of PD-1 gene polymorphism with drug efficacy and safetyin patients with head and neck squamous cell carcinoma

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123139) titled 'Establishment of a new method for blood concentration of camrelizumaband association of PD-1 gene polymorphism with drug efficacy and safetyin patients with head and neck squamous cell carcinoma' on April 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

Condition: Head and Neck Squamous Cell Carcinoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-05-05

Target Sample Size: Camrelizumab trial group (exposed group):100;

Countries of Recruitment: China

To know mo...